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Abstract
Bone loss associated with degenerative disease and trauma 
is a clinical problem increasing with the aging population. 
Thus, efective bone augmentation strategies are required; 
however, many have the disadvantages that they require 
invasive surgery and often the addition of expensive 
growth factors to induce osteoblast diferentiation. Here, 
we investigated a Laponite crosslinked, pNIPAM-
DMAc copolymer (L-pNIPAM-co-DMAc) hydrogel 
with hydroxyapatite nanoparticles (HAPna), which can 
be maintained as a liquid ex vivo, injected via narrow-
gauge needle into affected bone, followed by in situ 
gelation to deliver and induce osteogenic diferentiation 
of human mesenchymal stem cells (hMSC). L-pNIPAM-
co-DMAc hydrogels were synthesised and HAPna added 
post polymerisation. Commercial hMSCs from one donor 
(Lonza) were incorporated in liquid hydrogel, the mixture 
solidiied and cultured for up to 6 weeks. Viability of hMSCs 
was maintained within hydrogel constructs containing 
0.5 mg/mL HAPna. SEM analysis demonstrated matrix 
deposition in cellular hydrogels which were absent in 
acellular controls. A signiicant increase in storage modulus 
(G’) was observed in cellular hydrogels with 0.5 mg/mL 
HAPna. Semi-quantitative immunohistochemistry and 
histological analysis demonstrated that bone diferentiation 
markers and collagen deposition was induced within 48 h, 
with increased calcium deposition with time. The thermally 
triggered hydrogel system, described here, was suicient 
without the need of additional growth factors or osteogenic 
media to induce osteogenic diferentiation of commercial 
hMSCs. Preliminary data presented here will be expanded 
on multiple patient samples to ensure diferentiation is seen 
in these samples. This system could potentially reduce 
treatment costs and simplify the treatment strategy for 
orthopaedic repair and regeneration.
Keywords: Injectable hydrogel, stem cells, thermally 
responsive, bone regeneration, hydroxyapatite 
nanoparticles.
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Introduction
Traditionally, the use of bone autografts has been regarded 
as the gold standard clinical intervention for bone repair; 
however, this therapeutic strategy is limited by the amount 
of bone that can be used and poses clinical risk in terms 
of increased operative blood loss and donor-site morbidity 
(Goulet et al., 1997; Sen and Miclau, 2007). Consequently, 
a considerable amount of research has been undertaken 
which aims to develop efective regenerative strategies 
leading to bone augmentation (Kraus and Kirker-Head, 
2006; Mistry and Mikos, 2005). One group of potential 
biomaterials are hydrogels which are three-dimensional, 
insoluble, cross-linked, hydrophilic polymeric networks 
(Geckil et al., 2010) that can potentially be used to deliver 
cells with regenerative capacity and provide a scafold to 
facilitate cell growth, iniltration and diferentiation (Benoit 
et al., 2008; Park et al., 2007). Hydrogels are not generally 
considered as the material of choice for large bone defects, 
due to their weak mechanical properties; however, when 
taking a tissue engineered approach combining the use of 
cells, biological factors and scafolds, they ofer signiicant 
promise. In particular, temperature sensitive hydrogels are 
attractive since they can be applied as a liquid and gel in 
situ (Buwalda et al., 2014). An ideal hydrogel would be one 
which has a low viscosity to deliver cells and/or biological 
molecules, by minimally invasive injection, and ill micro 
and macro fractures followed by in situ gelation, assisting 
in the natural repair and regeneration of bone matrix. Such 
a material would be of particular use for osteoporosis, non-
union fracture, artiicial joint ixation and augmenting bone 
around dental implants or for treatment of bone defects 
in patients with periodontal disease. However, to date, 
the majority of developed hydrogel systems are not fully 
reacted in the liquid state and thus pose a signiicant safety 
risk to surrounding tissues and added cells during delivery, 
representing a signiicant challenge in the development of 
hydrogels for tissue engineering from concept to clinical 
application (Shin et al., 2003).
 Mesenchymal stem cells (MSC) are potentially the most 
attractive cell choice for bone regeneration since they can 
be extracted from a variety of adult tissues (Sakaguchi et 
al., 2005), they have proliferative capacity and thus can be 
easily cultured and expanded ex vivo, they host the ability to 
diferentiate into multiple cell lineages (Jiang et al., 2002) 
and inally they also avoid the ethical issues surrounding 
the use of embryonic stem cells. Recent studies have 
suggested that the source of MSCs are critical to the clinical 
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outcome with improved osteogenic diferentiation potential 
in bone marrow derived MSCs in comparison to synovial 
membrane and adipose tissue derived MSCs (Sakaguchi 
et al., 2005; Yoshimura et al., 2007). Rational design of 
biomaterial scafolds to promote osteogenic diferentiation 
of MSCs, should aim to create a cellular microenvironment 
that mimics the natural bone architecture and extracellular 
matrix (ECM) and thus provides the necessary biological, 
chemical and physical cues (Owen and Shoichet, 2010). 
Regenerating the complex nanostructure of bone, 
comprising of nanocrystals of carbonated apatite embedded 
within a rich collagenous fibrous matrix, has been a 
signiicant challenge for hydrogel based scafolds due 
to poor mineralisation following implantation (Gkioni 
et al., 2010). However, bioactivity of hydrogels can be 
improved by the addition of ceramic phases, such as 
hydroxyapatite (HAP), which is the inorganic component 
of bone and constitutes 60 % of native bone ECM (Weiner 
and Traub, 1992). Synthetic HAP: (CA
10
(PO
4
)(OH)
2
), has 
been extensively studied as a supplementary addition to 
hydrogel scafolds for bone regeneration, it has been shown 
to hold signiicant osteoconductive properties (Dhivya et 
al., 2015; Isikli et al., 2012; Na et al., 2007, Venugopal 
et al., 2010; Zhao et al., 2006) and is commonly used for 
coating of prosthetic joints to aid bone ixation (Furlong 
and Osborn, 1991; Nilsson et al., 1999). Furthermore, 
dispersed mineral within biomaterial scafolds has been 
shown to enhance mechanical properties (Sinha et al., 
2007), provide nucleation sites for further HAP deposition, 
as well as providing critical cellular anchoring points, 
which not only enable integration with surrounding bone 
tissue, but have also been shown to regulate the fate of 
cellular diferentiation (Kim et al., 2007; Rea et al., 2004; 
Trappmann et al., 2012; Zhao et al., 2006).
 A variety of injectable hydrogel scafolds for tissue 
regeneration have been reported (D’Este and Eglin, 
2013); however, many systems require co-injection with 
cross linking agents (Halacheva et al., 2014; Lally et al., 
2007; Saunders et al., 2007; Shin et al., 2003) which 
can result in toxicity to the delivered cells as well as 
the surrounding tissues during injection. Other systems 
are too viscous for injection through ine-bore needles, 
which may damage the target site and limit the potential 
of clinical applications (Michalek et al., 2010; Nassr et 
al., 2009). Similar pNIPAM/HAP hydrogels for bone 
repair have been reported; however, the viability of cells 
incorporated prior to gelation has not always been assessed 
(Couto et al., 2009) or the use of growth factors has been 
necessary to induce osteogenesis (Kim et al., 2007; Kim 
et al., 2011; Liao et al., 2011; Martínez-Sanz et al., 2011; 
Na et al., 2007) – thus adding both complexity and cost to 
the treatment strategy if these approaches were to be used 
clinically. Wei et al. (2009) reported a cytocompatible 
pNIPAM grafted HA surface material which supported 
mineralisation; however, a surface material alone is 
insuicient to act as a three dimensional cell delivery 
carrier capable of illing complex tissue cavities in vivo.
 Despite substantial advances in the development of 
hydrogels as regenerative delivery scafolds for bone 
augmentation, the ideal load bearing hydrogel that is 
feasible in terms of clinical application and meets all 
requirements including: biocompatibility, bioactivity and 
injectability, without the need for additional osteogenic 
inducing factors, is yet to be produced. We have previously 
reported the development of a synthetic hydrogel delivery 
system which exploits the thermal phase transition of 
pNIPAM and its ability to form electrostatic interactions 
with Laponite surfaces (Boyes et al., 2012a; Boyes et 
al., 2012b). Laponite is a synthetic smectite clay with a 
well-deined structural chemical composition, commonly 
used in household paper and polymer products. It has Mg2+ 
Li+ cations in the octahedral sites, with Na+ cations within 
the interlayer space. The idealised formula for Laponite 
is Na
0.7
[Mg
5.5
Li
0.4
 Si
8
O
20
(OH)
4
], and the platelets are 
typically ~ 30 nm in diameter with a thickness of 0.92 nm 
(Willenbacher, 1996). The polymerisation is carried out 
using azobisisobutyronitrile (AIBN), which undergoes 
thermal dissociation at temperatures above which pNIPAM 
will polymerise in a hydrophobic, globule conformation. 
This results in polymerisation and chain propagation close 
to the Laponite® surface, where the polymer/Laponite® 
particles exist as discrete entities in a stable low viscosity 
colloidal suspension. This unique colloidal system remains 
stable, provided the pNIPAM chains are maintained at 
temperatures that ensure they remain in their globule 
conformation. Upon cooling, the pNIPAM chains transform 
from the globule to the coil conformation, the polymer 
chains extend outwards forming bridging interactions 
with neighbouring clay platelets and entanglements with 
adjacent uncoiling polymer chains. The combination 
of NIPAM with a second monomer DMAc prior to 
polymerisation results in a crosslinked, 3-dimensional 
hydrated pNIPAM-DMAc statistical copolymer network 
which gels upon cooling below 37.1 ± 0.16 °C and does not 
re-liquefy at elevated temperatures. The hydrogel delivery 
system developed enables the incorporation of cells and 
injection whilst in the liquid state via small-bore needles, 
prior to them forming hydrogels in situ without the use of 
any additional, potentially toxic, reactive agents (Boyes 
et al., 2012a; Boyes et al., 2012b; Thorpe et al., 2016). 
We have previously demonstrated, through cell viability 
studies, that cells could survive, adhere to the hydrogel 
surface, migrate through the hydrogel and deposit matrix 
(Boyes et al., 2012b) and recently we have shown the basic 
hydrogel system promotes MSC diferentiation towards 
nucleus pulposus cells (Thorpe et al., 2016). The aim of 
this study, was to test the hypothesis that an injectable 
Laponite crosslinked, pNIPAM-DMAc copolymer 
(L-pNIPAM-co-DMAc) hydrogel delivery system, loaded 
with hydroxyapatite nanoparticles (HAPna), would 
be structurally sufficient alone to deliver and induce 
osteogenic diferentiation of hMSCs without the need for 
additional osteogenic inducing factors. Here, we added 
hMSCs into a thermally responsive hydrogel system, 
containing HAPna which can be maintained as a liquid 
prior to gelation at < 37.1 ± 0.16 °C. The relative simplicity 
and clinical convenience of such a method could provide 
an efective and minimally-invasive treatment platform for 
regeneration of bone in a variety of applications.
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Materials and Methods
Hydrogel synthesis
An exfoliated suspension of Laponite® clay nanoparticles 
(25-30 nm diameter, < 1 nm thickness) (BYK Additives 
Ltd, Cheshire UK) was prepared by vigorous stirring of 
Laponite (0.1 g) in deionised H
2
0 (18 mΩ) (9.0 mL) 
for 24 h. N-isopropylacrylamide 99 % (NIPAM) 
(0.783 g) (Sigma, Poole, UK), N, N’ -dimethylacrylamide 
(DMAc) (0.117 g) (Sigma, Gillingham, UK) and 
2-2’-azobisisobutyronitrile (AIBN) (9 mg) (Sigma, Poole, 
UK) were added to the suspension and stirred for 1 h. 
After passing the suspension through a 5-8 µm pore ilter 
paper, polymerisation was initiated by heating to 80 °C 
and the reagents were allowed to react for 24 h. It was 
observed that after heating the monomeric suspension 
to 80 °C, the transparent liquid transforms to a milky 
suspension. Following 24 h the hydrogel suspension, a 
statistical copolymer with a composition of 1 % Laponite, 
7.83 % NIPAM, 1.17 % DMAc and 90 % water (by 
weight), (MW of resulting hydrogel: 750 kDa) (Boyes et 
al., 2012a; Boyes et al., 2012b; Thorpe et al., 2016), was 
cooled to 50 °C and hydroxyapatite nanoparticles (HAPna) 
(< 200 nm) (Sigma, Poole UK) were homogenously 
mixed into the liquid hydrogel suspension (viscosity at 
54 °C: 0.97 MPa/s) at either 0.5 mg/mL or 1.0 mg/mL. 
The hydrogel/HAPna suspension was cooled to 38-39 °C 
prior to cell incorporation. Further cooling of the polymeric 
suspension to 37 °C, i.e. below the gelation temperature 
of 37.1 ± 0.16 °C, resulted in a solidified hydrogel 
(supplementary video 1, available from the ecmjournal.
org website page for this paper). The absence of unreacted 
NIPAM in the system was conirmed using diferential 
scanning calorimetry (DSC).
Material characterisation
Dynamic mechanical analysis (DMA)
DMA was performed on no cell control hydrogel samples, 
without culture, in triplicate using a PerkinElmer DMA8000 
model in conined compression mode at 25 °C, applying a 
sinusoidal force with a 0.02 mm displacement from 0.63 
to 10 Hz. Liquid L-pNIPAM-co-DMAc hydrogel was 
prepared, solidiied and stored for 2 h at room temperature 
in an air-lock sealed bag; following this a circular biopsy 
punch (5 mm i.d.) was used to remove cylindrical samples 
from the solid hydrogel. All sample dimensions were 
conirmed using digital callipers prior to measurement.
Gelation Temperature
 Liquid L-pNIPAM-co-DMAc hydrogel suspension with 
0.5 mg/mL HAPna was synthesised and allowed to cool to 
room temperature. A digital calibrated thermometer was 
used to measure the temperature at which gelation of the 
hydrogel was initiated. Six replicate measurements were 
taken from 3 separately prepared hydrogel batches (Table 
1).
Expansion and incorporation of human mesenchymal 
stem cells in hydrogels
Commercial bone marrow derived human adult 
mesenchymal stem cells (hMSCs) extracted from a 38 y 
old donor (Lonza, Slough, UK) were cultured in DMEM 
media (Life Technologies, Paisley, UK), supplemented 
with heat inactivated foetal calf serum (FCS) (10 % v/v) 
(Life Technologies, Paisley, UK), Penicillin (100 U/mL) 
(Life Technologies Paisley, UK), Streptomycin (100 µg/
mL) (Life Technologies Paisley, UK), amphotericin 
(250 ng/mL) (Sigma, Poole UK), glutamine (2 mM) (Life 
Technologies, Paisley, UK) and ascorbic acid (10 µg/mL) 
(Sigma, Poole, UK) (complete cell culture media). MSCs 
were expanded in monolayer culture to passage 9 to ensure 
suicient cells were available. Cell seeding solutions were 
prepared at a density of 1 × 106 cells/mL, homogenously 
mixed with the L-pNIPAM-co-DMAc hydrogel suspension 
(38-39 °C) containing either 0.5 or 1.0 mg/mL HAPna 
(Sigma, Poole, UK) and 300 µL added into the middle 
wells of a sterile 48-well culture plate by 26-gauge needle 
injection (Becton Dickinson, Plymouth, UK), leaving the 
outer wells void of hydrogel. Phosphate bufered saline 
(PBS) (300 µL) (Life Technologies, Paisley, UK) was 
pipetted into all outer wells of the 48-well plates to prevent 
drying of hydrogel constructs. 300 µL of L-pNIPAM-co-
DMAc hydrogel suspension, without cells, containing 
either 0.5 or 1.0 mg/mL HAPna were also added into 
wells of a sterile 48-well culture plate, by 26-gauge needle 
injection, to serve as acellular controls. All acellular and 
hMSC hydrogel scafolds were cultured in complete cell 
culture media (as described above) by careful overlay 
of 1.0 mL of medium per construct, incubated at 37 °C, 
5 % CO
2
 and maintained in culture for up to 6 weeks. 
Media were collected and replaced every 2-3 d. Samples 
were removed after 48 h, 1, 2, 4 and 6 weeks for analysis 
of cell viability, scanning electron microscopy (SEM), 
histological assessment of matrix deposition and hMSC 
differentiation analysis using immunohistochemistry 
(IHC). Additional samples were also extracted after 4 and 
6 weeks to assess the mechanical properties using dynamic 
mechanical analysis (DMA). All experimental procedures 
were repeated at least 3 times.
Cytospins
IHC was performed on hMSCs taken from monolayer 
culture prior to hydrogel encapsulation to serve as time 
zero controls. Monolayer cells were trypsinised and cells 
were ixed in paraformaldehyde/PBS (4 % w/v) (Sigma, 
Poole, UK) for 20 min, spun at 300 ×g for 5 min to form 
a cell pellet and resuspended in PBS to a cell density of 
300 cells/µL. 100 µL of cell suspension was then cytospun, 
formed by centrifugation at 1000 rpm for 3 min (Shandon 
Cytospin 3, Thermo Scientific, Loughborough UK). 
Slides were subsequently air-dried and stored at 4 °C until 
required for IHC analysis.
Cytocompatibility assessment of hydroxyapatite 
hydrogel scafolds
The metabolic cell activity of hMSCs incorporated into 
solidiied L-pNIPAM-co-DMAc hydrogels containing 
either 0, 0.5 or 1.0 mg/mL HAPna at a density of 
1 × 106 cells/mL were assessed using Alamar Blue 
assay (Life Technologies, Paisley, UK) in normal 
complete media following 0, 1, 2, 3, and 7 d using the 
manufacturers protocol. The luorescence was recorded 
4
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Table 2. Immunohistochemistry Reagents.
Target antibodies used for IHC (abcam), their optimal concentrations and antigen retrieval methods. No antigen 
retrieval (NAR), enzyme induced antigen retrieval (EAR). Full method instructions detailed in Materials and Methods 
section.
Primary antibody Clonality Optimal Dilution Antigen Retrieval Blocking Serum Secondary Antibody
Runx2 Mouse monoclonal 1:200 NAR Rabbit Rabbit anti-mouse
Collagen I Mouse Monoclonal 1:200 EAR Rabbit Rabbit anti-mouse
Collagen II Mouse Monoclonal 1:100 NAR Rabbit Rabbit anti-mouse
Collagen X Mouse Monoclonal 1:400 EAR Rabbit Rabbit anti-mouse
Osteopontin Mouse Monoclonal 1:400 NAR Rabbit Rabbit anti-mouse
Osteocalcin Mouse Monoclonal 1:400 EAR Rabbit Rabbit anti-mouse
Aggrecan Mouse Monoclonal 1:200 NAR Rabbit Rabbit anti-mouse
Table 1. Gelation temperature of Liquid L-pNIPAM-co-DMAc hydrogel 
suspension with 0.5 mg/mL HAPna, determined using a digital calibrated 
thermometer.
L-pNIPAM-co-DMAc
Batch 1 (°C)
L-pNIPAM-co-DMAc
Batch 2 (°C)
L-pNIPAM-co-DMAc
Batch 3 (°C)
37.2 37.4 36.8
36.9 37.1 37.1
37.3 37.4 37.3
37.1 37.3 37.1
37.0 37.0 37.2
37.3 37.2 37.0
using a luorescence microplate reader (CLARIOstar® is 
BMG LABTECH) luorescence excitation wavelength of 
590 nm. Relative luorescence units were recorded and 
normalised to acellular control hydrogels as an indication 
of cytotoxicity/proliferation.
Dynamic mechanical analysis
Acellular and hMSC L-pNIPAM-co-DMAc hydrogels, 
cultured in MSC medium, containing either 0.5 mg/mL or 
1.0 mg/mL HAPna were characterised for their mechanical 
properties after 4 and 6 weeks in culture. Replicate samples 
were removed from culture, blotted and their mechanical 
properties characterised by DMA. Samples were extracted 
using a 5 mm circumference circular biopsy punch, all 
sample heights were measured and recorded using digital 
callipers prior to measurement. Triplicate samples were 
analysed using a PerkinElmer DMA8000 model under 
conined compression mode at 25 °C, applying a sinusoidal 
force with a 0.02 mm displacement at frequencies between 
1-10 Hz.
Hydration degree
To evaluate the hydration degree of the hMSC and acellular 
L-pNIPAM-co-DMAc hydrogel scaffolds with 0.5 or 
1.0 mg/mL HAPna, samples were extracted from culture 
in triplicate following 48 h, 1, 2, 4 and 6 weeks and the 
wet weight (M
o
) of the samples was measured. Samples 
were then lyophilised for 8 h to obtain the dry weight (M
t
). 
The hydration degrees of the hMSC and acellular hydrogel 
scafolds were calculated using the following equation:
            (1)
Scanning electron microscopy (SEM)
Samples were removed from culture after 48 h, 1, 2, 4 and 6 
weeks, frozen at -80 °C and subsequently freeze dried using 
a FD-1A-50 Freeze Drier set to −53 °C, 3.8 × 10-4 mbar for 
8 h. The sample was then fractured to expose the interior 
surface morphology attached onto an aluminium stub and 
then using a Quorum Technology 150 Q TES system coated 
with either gold (10 µA sputter current for 180 s with a 
2.7 tooling factor) for imaging or with 15 nm carbon for 
energy dispersive X-ray (EDX) analysis.
 The fracture surfaces were examined using a FEI 
NOVA nanoSEM 200 scanning electron microscope 
(SEM). Secondary electron (SE) images were obtained 
using accelerating voltage 5 kV at various magniications 
ranging from 1,000 × to 40,000 ×. Images were captured 
and pore sizes (µm) measured using the Capture Pro OEM 
v8.0 software (Media Cybernetics, Buckinghamshire, UK) 
with 200 pores selected at random from 10 separate images 
for each given time point.
 The SEM was equipped with an Oxford Instruments 
EDX analyser incorporating an X-Max silicon drift 
detector (SDD) and Aztec Energy software. This allowed 
regions of interest to be scanned and subsequently analysed 
providing elemental spectra data on selected features.
Matrix deposition within hydrogel constructs
Matrix deposition was investigated in HAPna hydrogels 
with or without cells following 48 h, 1, 2, 4 and 6 weeks. 
Triplicate samples were removed from culture and ixed 
in paraformaldehyde/PBS (4 % w/v) overnight prior to 
washing in PBS and embedding to parain wax using the 
TP1020 tissue processor (Leica Microsystems, Milton 
Keynes UK). Following embedding, 4 μm sections 
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were cut and mounted to positively charged slides 
(Leica Microsystems, Milton Keynes, UK). Sections 
were dewaxed in Sub-X (Leica Microsystems, Milton 
Keynes, UK) (3 × 5 min), rehydrated in IMS (Fisher, 
Loughborough, UK) (3 × 5 min) and washed in distilled 
water (5 min). Sections were then stained in either Alizarin 
Red (2 % w/v, pH 4.2) (Sigma Aldrich, Poole, UK) for 
15 min, Alcian Blue (1 % w/v, pH 2.5) (Sigma Aldrich, 
Poole, UK) in acetic acid (3 % v/v) (Sigma Aldrich, Poole, 
UK) for 5 min with neutral red (1 % w/v) (Sigma Aldrich, 
Poole, UK) used as a counter stain for 2 min or stained 
with Masson’s trichrome (Miller& Miller Ltd, Hainault, 
UK) according to the manufacturer’s instructions. Sections 
were dehydrated in IMS (4 × 10 min), cleared in Sub-X 
(3 × 5 min) and mounted in Pertex (Leica Microsystems, 
Milton Keynes, UK). All slides were examined with 
an Olympus BX51 microscope and images captured 
by digital camera and Capture Pro OEM v8.0 software 
(Media Cybernetics, Buckinghamshire, UK). Histological 
sections were analysed, features noted and images were 
captured to document their histological appearance. The 
matrix staining intensity was then evaluated using line-
proile analysis on the Capture Pro OEM v8.0 software 
(Media Cybernetics, Buckinghamshire, UK). An image 
was captured for each triplicate sample following 48 h 1, 
2, 4 and 6 weeks, 10 random ields were selected per image 
and line proile analysis undertaken, which provides index 
values as a measure of intensity for each pixel position in 
the selected ield. The index values per ield were averaged 
to give 10 intensity measurements per triplicate sample and 
thus 30 measurements per time point.
Immunohistochemistry
Protein expression of collagen type X, a marker of late 
stage chondrocyte hypertrophy, the osteoblast speciic 
transcription factor runx2 and osteogenic matrix markers 
collagen type I, osteocalcin and osteopontin were selected 
for immunohistochemistry (IHC) investigation to assess 
the osteogenic diferentiation capacity of hMSCs cultured 
in L-pNIPAM-co-DMAc hydrogel constructs containing 
0.5 mg/mL HAPna. Additionally, protein expression of 
aggrecan and collagen type II were also selected for IHC 
investigation to assess chondrogenesis. All IHC analysis 
was performed on acellular L-pNIPAM-co-DMAc 
hydrogel constructs containing 0.5 mg/mL HAPna for each 
time point investigated to serve as background controls. 
IHC analysis was not undertaken on hMSC or acellular 
hydrogel constructs containing 1.0 mg/mL HAPna due to 
evidence of cytotoxicity, reduced matrix deposition and 
reduced mechanical properties observed in these constructs. 
Sections were prepared as described for histological 
analysis; IHC was performed as previously described 
(Le Maitre et al., 2005). Briely, 4 μm parain sections 
were de-waxed, rehydrated and endogenous peroxidase-
blocked using hydrogen peroxide (Sigma, Aldrich Poole 
UK). After washing in tris-bufered saline (TBS; 20 mM 
tris, 150 mM sodium chloride, pH 7.5), sections were 
subjected to either no antigen retrieval (NAR) or enzyme-
induced antigen retrieval (EAR) (30-min incubation in 
TBS; 20 mM tris, 150 mM sodium chloride, 46.8 mM 
calcium chloride dihydrate) (Fisher, Loughborough UK) 
pH 7.5, containing 0.01 % w/v α-chymotrypsin (Sigma 
Aldrich, Poole UK) from bovine pancreas at 37 °C 
(Table 2). Following TBS washing, nonspeciic binding 
sites were blocked at room temperature for 90 min with 
serum (25% w/v) (Abcam, Cambridge, UK) (Table 2) 
in bovine serum albumin in TBS (1 % w/v). Sections 
were incubated overnight at 4 °C with the appropriate 
primary antibody (Table 2). Negative controls, in which 
mouse or rabbit IgGs (Abcam Cambridge UK) replaced 
the primary antibody at an equal protein concentration, 
were used (Table 2). After washing in TBS, sections were 
incubated in 1:500 biotinylated secondary antibody (Table 
2). Disclosure of secondary antibody binding was by the 
HRP-streptavidin biotin complex (30 min incubation) 
(Vector Laboratories, Peterborough, UK), TBS washing, 
followed by application of hydrogen peroxide (0.08 % v/v) 
in 3,3’-diaminobenzidine tetrahydrochloride (0.65 mg/mL) 
(Sigma Aldrich, Poole UK) in TBS (20 min incubation). 
Sections were counterstained with Mayer’s haematoxylin 
(Leica Microsystems, Milton Keynes UK), dehydrated in 
IMS (Fisher, Loughborough UK) (4 × 10 min), cleared 
in Sub-X (Leica Microsystems, Milton Keynes UK) 
(3 × 5 min) and mounted in Pertex (Leica Microsystems, 
Milton Keynes UK). All slides were visualised using 
an Olympus BX51 microscope and images captured 
by digital camera and Capture Pro OEM v8.0 software 
(Media Cybernetics, Buckinghamshire, UK). Evaluation 
of IHC staining was performed by counting immuno 
positive and immuno negative cells for each section and 
immunopositive cells expressed as a percentage of total 
count.
Feasibility testing of injection into bone
Liquid L-pNIPAM-co-DMAc hydrogel was injected via a 
26-gauge needle into a bovine tail vertebra to simulate the 
potential clinical application. A 3 mm bore hole was irst 
created in the cortical bone to facilitate needle insertion. 
A blue dye was incorporated into the liquid L-pNIPAM-
co-DMAc hydrogel to aid visualisation within the bone 
following injection. L-pNIPAM-co-DMAc hydrogel was 
cooled and maintained at 39 °C in a water bath prior to 
injection. Approximately 100 µL of liquid L-pNIPAM-co-
DMAc hydrogel was then injected into the centre of the 
bovine tail vertebra in a temperature controlled glove box 
set at 37 °C. The vertebra was then cut open and photos 
captured to investigate the ability of the hydrogel to be 
injected into bone, ill the voids between the bone trabecula 
and solidify following injection. Bovine tail vertebrae, 
without the injection of hydrogel, were also cut open and 
images captured to serve as controls.
Data processing and statistical analysis
All tests were performed at least in triplicate. Data were 
assessed for normality using the Shapiro Wilks test and 
found to be non-normally distributed, as such data were 
non-parametric and hence statistical comparisons were 
performed by Kruskal-Wallis for pairwise comparisons 
(Conover-Inman) with statistical signiicance accepted at 
p ≤ 0.05. Pairwise comparisons were made as follows: 0 
days compared with 1, 2, 3 and 7 d for Alamar Blue assay 
(Fig. 1); 0.5 compared with 1.0 mg/mL HAPna as well 
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as hMSC compared with acellular hydrogels for DMA 
(Fig. 2A,B); 48 h hMSC hydrogels compared with all 
other hMSC scafolds following 1, 2, 4 and 6 weeks for 
pore sizes (Fig. 4C), total mass, water mass, dry mass and 
hydration degree (Fig. 2C-H) and matrix staining intensity 
measurements (Fig 6A-C); monolayer controls compared 
with all other time points investigated for IHC (Fig. 9). 
Data were then presented on graphs; all replicates have 
been shown with median value indicated to demonstrate 
clearly the spread of replicates.
Results
Cytocompatibility assessment of hydroxyapatite 
hydrogel scafolds
Alamar Blue assay, as a measure of metabolic cell activity 
and thus the total number of viable cells, was assessed 
over 7 d in culture (Fig. 1). No signiicant diference in 
metabolic cell activity was detected over the 7 d culture 
period where hMSCs were incorporated into L-pNIAPM-
co-DMAc hydrogel constructs without HAPna (Fig. 1A) 
and with 0.5 mg/mL HAPna (Fig. 1B). A significant 
decrease in metabolic cell activity was observed from 0 to 
2 d (p = 0.0191), 3 days (p = 0.0001) and 7 d (p = 0.0001) 
in culture, with increasing HAPna concentration to 1.0 mg/
mL HAPna (Fig. 1C).
Mechanical properties
The mechanical properties of acellular control and hMSC 
L-pNIPAM-co-DMAc hydrogels, prior to culture (Fig. 2A) 
and following culture in MSC medium with and without 
incorporation of MSCs, containing either 0.5 mg/mL or 
1.0 mg/mL HAPna were characterised using DMA under 
conined compression after 4 and 6 weeks in culture (Fig. 
2B,C). The elastic modulus (G’) values, for all hydrogel 
formulations, did not increase as a function of increasing 
frequency indicating that both acellular and hMSC 
HAPna hydrogels did not exhibit typical viscoelastic 
behaviour (Fig. 2A,B,C). Since the elastic modulus for 
all formulations was frequency independent, 1 Hz was 
selected to compare potential diferences in the mechanical 
properties between hMSC and acellular HAPna hydrogel 
scafolds (Fig. 3A,B). The G’ of no cell control L-pNIPAM-
co-DMAc hydrogels prior to culture with either 0.5 mg/
mL or 1.0 mg/mL HAPna was 0.99 MPa (range 0.91-1.11) 
and 1.16 (range 0.71-1.57) respectively (Fig. 2A,B,C), with 
no signiicant change upon culture for 6 weeks without 
cells (Fig. 2A,B,C). Observations revealed a higher G’ in 
hMSC hydrogel constructs with 0.5 mg/mL HAPna after 
both 4 and 6 weeks culture with a signiicantly higher G’ 
observed following 6 weeks in comparison with acellular 
hydrogels with 0.5 mg/mL HAPna (p = 0.0395) and 1.0 mg/
mL HAPna (p = 0.0005) (Fig. 3B). A signiicantly higher 
G’, following 6 weeks in culture, was also observed in 
hMSC hydrogel constructs with 0.5 mg/mL HAPna is 
comparison to hMSC hydrogels containing 1.0 mg/mL 
HAPna (p = 0.0063) (Fig. 3B). Similarly, an increase in 
G’ in hMSC hydrogels containing 1.0 mg/mL HAPna 
following 6 weeks culture (although not signiicant) was 
observed in comparison to acellular hydrogels containing 
1.0 mg/mL HAPna (Fig. 3A,B). Acellular hydrogels 
containing 0.5 mg/mL HAPna also displayed a signiicantly 
higher elastic modulus following 6 weeks in culture 
compared to acellular hydrogels containing 1.0 mg/mL 
HAPna (p = 0.0176) (Fig. 3B).
Gelation temperature
The gelation temperature of Liquid L-pNIPAM-co-DMAc 
hydrogel suspension with 0.5 mg/mL HAPna, determined 
using a digital calibrated thermometer, was shown to be 
37.1 ± 0.16 °C (Table 1).
Structural and compositional requirements for bone 
regeneration
Hydration assessment
The addition of hMSCs to hydrogel scafolds constricted 
the scafold size (Fig. 4D). A signiicant loss of water was 
Fig. 1. In vitro cell proliferation using Alamar blue 
assay of hMSC incorporated into L-pNIPAM-co-DMAc 
hydrogel (A), incorporated with 0.5 mg/mL HAPna 
(B) or 1.0 mg/mL HAPna (C) following 7 d in culture. 
Relative luorescence units (RFU) normalised to acellular 
controls. *p ≤ 0.05.
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Fig. 2. Dynamic Mechanical Analysis: (A) 
G’ values of acellular L-pNIPAM-co-DMAc 
hydrogels containing either 0.5 or 1.0 mg/
mL HAPna prior to culture (storage time 
2 h), under conined compression from 0.63 
to 10 Hz. (B,C) Acellular control and hMSC 
L-pNIPAM-co-DMAc hydrogels containing 
0.5 or 1.0 mg/mL HAPna, afer 4 (B) and 6 (C) 
weeks in culture under conined compression 
from 0.63 to 10 Hz.
observed where hMSC were added to hydrogel scafolds 
from 48 h to 6 weeks (p < 0.0001) in culture (Fig. 2C,D), 
thus causing a reduction in the hydration degree from 
79 ± 4.5 % after 48 h in culture to 54 ± 3.5 % after 6 
weeks in culture with 0.5 mg/mL HAPna (Fig. 2G) and 
85 ± 1 % after 48 h to 64.5 ± 2.5 % after 6 weeks in culture 
with 1.0 mg/mL HAPna (Fig. 2H). A signiicant increase 
(p = 0.0342) in the dry mass of hMSC hydrogel scafolds 
was observed after 6 weeks in culture containing 0.5 mg/
mL HAPna in comparison to 48 h (Fig. 2E).
Scanning electron microscopy
The interior micro-scale morphology of acellular and 
hMSC HAPna L-pNIPAM-co-DMAc hydrogels were 
examined using scanning electron microscopy (SEM) (Fig. 
4A,B). Acellular hydrogels containing 0.5 or 1.0 mg/mL 
HAPna after 48 h, 2, 4 and 6 weeks in culture displayed 
a comparatively uniform interconnecting porous network 
(Fig. 4A,B), with a median pore size of 10 µm (range 1.5-
34 µm) (Fig. 4C). Where hMSCs were incorporated into 
hydrogels prior to solidiication, cells were seen to occupy 
the pores of the structure with a rounded morphology after 
48 h in culture (Fig. 4A,B). A progressive increase in the 
structural density was visible within hMSC hydrogels 
containing 0.5 mg/mL HAPna from 2 to 6 weeks (Fig. 
4A) with a signiicant decrease in pore size from 48 h to 2 
weeks in culture (p < 0.0001), which subsequently became 
too small in diameter to obtain accurate measurements after 
2 weeks in culture (Fig. 4C). An increase in the structural 
density of hMSC hydrogels containing 1.0 mg/mL HAPna 
was also observed however the structural morphology of 
the entire construct was not uniform, with areas of high 
porosity visible following 6 weeks in culture (Fig. 4B). 
Pore sizes of hMSC scafolds with 1.0 mg/mL HAPna 
were measured throughout the 6 week culture period with 
a signiicant decrease in pore size shown from 48 h to 6 
weeks in culture (p < 0.0001) (Fig. 4C).
Histological and elemental assessment
The composition of the matrix was assessed histologically 
and found to consist of collagen, identiied by Masson’s 
trichrome (Fig. 5), with a significant increase in the 
matrix staining intensity following culture for 1 week 
(p = < 0.001), 4 weeks (p = 0.0092) and 6 weeks 
(p = < 0.001) in comparison to 48 h in culture (Fig. 6A), 
as well as calcium deposition conirmed by alizarin red 
staining (Fig. 5), with a signiicant increase in the matrix 
staining intensity following culture for 4 weeks (p = 0.01) 
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Fig. 3. Structural and Mechanical Characterisation of L-pNIPAM-co-DMAc hydrogels with either 0.5 or 1.0 mg/mL 
HAPna, with hMSC (red) or acellular (NC) controls (black). G’ values of hMSC and acellular (NC) hydrogels containing 
either 0.5 or 1.0 mg/mL HAPna after 4 (A) and 6 (B) weeks in culture, under conined compression at 1 Hz. Water mass 
(C,D), dry mass (E,F) and calculated hydration degree (G,H) of hMSC (MSC) and acellular control (NC) hydrogels 
containing either 0.5 (C,E,G) or 1.0 mg/mL (D,F,H) HAPna throughout 6 weeks in culture. Statistical signiicance 
compared to 48 h hMSC indicated. All replicates shown with median values indicated. *p ≤ 0.05.
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Fig. 4. Scanning electron microscopy (SEM) of hMSC and acellular hydrogels with 0.5 mg/mL HAPna (A) or 
1.0 mg/mL HAPna (B) from 48 h to 6 weeks in culture, scale bar 10 µm. (C) pore sizes (µm) for hMSC and 
acellular (NC) hydrogels. (D) Images of hydrogels with 0.5 mg/mL HAPna in culture demonstrating constriction 
in hydrogel size where hMSCs had been incorporated, images captured following 1 week in culture. Statistical 
signiicance compared to 48 h hMSC indicated. All replicates shown with median values indicated. *p ≤ 0.05.
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and 6 weeks (p < 0.0001), compared to 48 h in culture 
(Fig. 6B). Mineralisation was further supported by the 
identiication of a calcium and phosphate peak observed 
using EDX spectra (Fig. 7). Histologically cells were also 
shown to produce proteoglycans as observed by Alcian 
Blue staining (Fig. 5), with a signiicant increase in the 
matrix staining intensity of hMSC hydrogels after 1 week 
(p = 0.0485) and 4 weeks (p < 0.0001) compared to those 
after 48 h (Fig. 6C); however, a signiicant increase in the 
matrix staining intensity, with alcian blue staining, was 
also observed in acellular controls following culture for 1 
week (p < 0.0001) and 6 weeks (p = 0.0023) compared to 
those after 48 h in culture (Fig. 6C).
Induction of osteogenic diferentiation
In the current study, the ability of 0.5 mg/mL HAPna loaded 
L-pNIPAM-co-DMAc hydrogels to induce osteogenic 
differentiation of bone marrow derived hMSCs was 
assessed by immunohistochemical analysis of hMSCs 
harvested directly from monolayer culture and after 
48 h, 1, 2, 4 and 6 weeks in hMSC hydrogels containing 
0.5 mg/mL HAPna for collagen type X (Fig. 8), a marker 
of chondrocyte hypertrophy associated with endochondral 
ossiication (Mwale et al., 2006), the osteoblast speciic 
transcription factor runx2 and bone matrix markers 
collagen type I, osteopontin and osteocalcin (Fig. 8). IHC 
for speciic antibodies for the chondrogenic markers: 
collagen type II and aggrecan were also performed to 
Fig. 5. Analysis of matrix deposition in L-pNIPAM-co-DMAc hydrogel constructs containing 0.5mg/mL HAPna 
using histological stains: Masson’s trichrome (MT) for collagen, alizarin red (AR) for calcium deposition and alcian 
blue (AB) for proteoglycans. Acellular control hydrogels shown following 6 wks in culture. Black arrows indicate 
negative cells, white arrows indicate positive matrix producing cells and blue arrows indicate formation of possible 
osteoid nodules. Scale bar 100 µm.
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conirm speciic matrix synthesis (Fig. 8). Collagen type 
X was ubiquitously expressed (100 %) by hMSCs prior to 
incorporation into 0.5 mg/mL HAPna hydrogels (Fig. 9), 
this was followed by a signiicant decrease in the number 
of immunopositive cells after culture for 48 h (p = 0.0016), 
1 (p = 0.0102), 2 (p = 0.0333) and 6 (p = 0.0056) weeks in 
hydrogels containing 0.5 mg/mL HAPna, in comparison 
to monolayer controls (Fig.9).
 Runx2 immunopositivity was signiicantly increased 
after culture for 48 h (p = 0.0258), 1 week (p = 0.0005) and 
2 weeks (p = 0.0221), in comparison to monolayer controls, 
after incorporation into hydrogels loaded with 0.5 mg/mL 
HAPna; this was followed by a signiicant decrease in the 
number of runx2 immunopositive cells from 2 to 4 weeks 
(p = 0.0018) in culture (Fig. 9).
 Collagen type I was found to be highly expressed by 
hMSCs harvested directly from monolayer culture (98 %) 
with a signiicant decrease in the number of immunopositive 
cells observed after culture for 48 h (p = 0.0073) and 1 
week (p = 0.0253), following incorporation into hydrogel 
constructs containing 0.5 mg/mL HAPna, in comparison 
to monolayer controls (Fig. 9). A signiicant increase 
in collagen type I cell immunopositivity was observed 
following 4 weeks (p = 0.0013) and 6 weeks (p = 0.0003) 
in culture, in comparison to the reduced expression 
observed after 48 h (Fig. 9). Expression of collagen type I 
was subsequently maintained at high levels with all three 
replicates displaying 100 % immunopositivity after 6 
weeks in culture (Fig. 9).
 Osteopontin and osteocalcin, two late phase markers 
of mature osteogenesis, were shown to be expressed by 
a signiicantly increased number of hMSCs (p < 0.0001) 
from 48 h to 6 weeks in culture, after incorporation into 
0.5 mg/mL HAPna hydrogel scafolds in comparison to 
monolayer controls (Fig. 9).
 The percentage cell immunopositivity for chondrogenic 
markers: aggrecan and collagen type II, remained 
unchanged (aggrecan) or was significantly decreased 
(collagen type II) following 4 (p = 0.0213) and 6 weeks 
(p = 0.042) in culture, after incorporation into 0.5 mg/mL 
HAPna hydrogel constructs in comparison to monolayer 
controls (Fig. 9).
Feasibility of injection into bone
Liquid L-pNIPAM-co-DMAc hydrogel containing 
0.5 mg/mL HAPna was maintained at 39 °C and injected 
through a 26-gauge needle at 37 °C demonstrating rapid 
gelation at 37 °C (Fig. 10A & Supplementary Video 
1). It is important to note that the liquid L-pNIPAM-
co-DMAc maintained at 39 °C remained in the liquid 
state and would do so indeinitely at this temperature. 
The proposed clinical application would be performed 
by combining liquid L-pNIPAM-co-DMAc hydrogel 
containing HAPna and previously extracted autologous 
MSCs prior to injection into the bone site required, where 
cooling to body temperature (37 °C) will result in gelation 
of the hydrogel system (Fig. 10B). To test the feasibility of 
application of the hydrogel into bone, liquid L-pNIPAM-
co-DMAc hydrogel containing 0.5 mg/mL HAPna with 
an incorporated blue dye for visualisation, was cooled to 
39 °C and injected into bovine tail vertebrae at 37 °C (Fig. 
10C). Following injection, the vertebrae was cut open and 
inspected, the hydrogel was found to have illed the voids 
between the bone trabecula and solidiied post-injection 
(Fig. 10C).
Fig. 6: Line proile analysis providing index values 
per pixel to calculate matrix staining intensity in 
hMSC (MSC) and acellular (NC) control L-pNIPAM-
co-DMAc hydrogel constructs containing 0.5 mg/mL 
HAPna using histological stains: Masson’s trichrome 
(A), alizarin red (B) and alcian blue (C). Statistical 
signiicance compared to 48 h hMSC and NC indicated. 
All replicates shown with median values indicated. 
*p ≤ 0.05.
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Discussion
Cytocompatibility assessment of hydroxyapatite 
hydrogel scafolds
The cytocompatibility of biomaterial scaffolds is a 
fundamental prerequisite for use therapeutically. The 
survival of cells incorporated into liquid hydrogel prior to 
gelation ofers key advantages, over previously developed 
pNIPAM hydrogels which required solidiication and 
puriication prior to the addition of cells, both of which 
eliminate any potential as an injectable delivery system 
(Haraguchi et al., 2006). Cell viability was maintained in 
0.5 mg/mL HAPna containing hydrogels, but no increase 
in cell number was seen indicating that cells were not 
proliferating in the hydrogel constructs; however, studies 
have shown that commitment to the osteogenic lineage, 
depicted by the up-regulation of the osteoblast speciic 
transcription factor runx2, results in down regulation of 
genes which are required for proliferation (Stein et al., 
2004). The structural limitations of a three-dimensional 
microenvironment and the increasing stiffness which 
can result from the addition of HAPna may also slow 
down cellular proliferation (Lei et al., 2011, Sun et al., 
1997). Interestingly, cytotoxic efects were observed with 
increasing HAPna concentration to 1.0 mg/mL HAPna. 
HAP cytotoxicity has been reported previously (Qing et 
al., 2012; Sun et al., 1997), in particular Sun et al., (1997) 
demonstrated that osteoblast cellular proliferation was 
signiicantly reduced when cultured in media containing 
HAP powder at a concentration of 1.0 mg/mL, as was used 
in this study, thus highlighting the importance of testing 
nanoparticle concentrations over a narrow range of the 
desired concentration to assess potential toxicity (Sun et 
al., 1997).
Mechanical properties
The unique nanostructure of bone ensures exceptional 
mechanical properties with an elastic modulus in the 
region of 14-20 GPa for cortical bone and approximately 
10 GPa for cancellous bone (Choi et al., 1990; Reilly et 
al., 1974; Rho et al., 1993; Rho et al., 1997; Rho et al., 
1998). Traditionally, hydrogels have been considered for 
the regeneration of soft tissues, due to their inherently 
weak mechanical properties, studies have also shown that 
addition of cells further exacerbates this problem (Kumar 
et al., 2014). However, observations in this study, revealed 
an increased elastic modulus from 1.21 MPa in acellular 
hydrogel scafolds with 0.5 mg/mL HAPna to 2.03 MPa 
in hMSC hydrogels with 0.5 mg/mL HAPna following 6 
weeks in culture, possibly due to a combination of matrix 
deposition and reduced hydration degree in cellular 
hydrogel scafolds.
 The decrease in elastic moduli observed with increasing 
HAPna concentration has been previously reported by 
Fig. 7. EDX spectra of L-pNIPAM-co-DMAc hydrogels with 0.5 mg/mL HAPna. Acellular control hydrogel after 
48 h in culture (A), hMSC hydrogel after 48 h in culture (B), acellular control hydrogel after 6 weeks in culture (C), 
hMSC hydrogel after 6 weeks in culture (D). SEM images illustrated inset, white box indicates where EDX spectra 
were collected. Scale bar 50 µm.
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Fig. 8. Immunohistochemical detection of osteogenic markers runx2, osteopontin, osteocalcin, collagen type I, collagen 
type X and negative markers collagen type II and aggrecan, prior to hydrogel incorporation (0 h) (monolayer control) 
and after 48 h and 6 weeks following incorporation into hydrogel. Acellular control hydrogels shown to match the 
time point at which % immunopositivity was highest: runx2, col type II (48 h), col type I, osteopontin, osteocalcin (6 
weeks), and aggrecan, col type X (4 weeks). Black arrows indicate positively stained cells and white arrows indicate 
negatively stained cells. Scale bar 100 µm.
14
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Fig. 9. Immunohistochemical detection of osteogenic markers runx2, osteopontin, osteocalcin, collagen type I, collagen 
type X and negative markers collagen type II and aggrecan prior to hydrogel incorporation (0h) (monolayer controls) 
and after 48 h, 1, 2, 4 and 6 weeks culture following incorporation into hydrogel. Percentage immunopositivity was 
calculated and statistical analysis performed to investigate change from control (*p ≤ 0.05).
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Pan et al., 2008, who observed a decrease in G’ with 
increasing HAPna content from 6 % to 9 % in poly (vinyl 
alcohol) gel biocomposites (Pan et al., 2008). It is well 
known that the addition of HAP can greatly afect the 
rheological properties of polymeric composites (Pan et al., 
2008), particularly at low HAP concentrations where the 
addition of HAPna has been shown to increase the stifness 
of composites due to the rigidity of HAPna (Pan et al., 
2008). However, the high surface energy of HAPna can 
cause them to agglomerate at high concentrations, which 
can lead to deterioration of mechanical properties (Liu et 
al., 1997). It could also be hypothesised that increasing 
the concentration of HAPna from 0.5 to 1.0 mg/mL 
HAPna results in an efective lower cross linking density, 
due to the HAPna competing with the pNIPAM amide 
groups on the gel backbone for interaction with exchange 
cations and electron rich areas on the Laponite surface. 
This phenomenon could explain the reduced mechanical 
properties observed here where 1.0 mg/mL HAPna was 
incorporated into hydrogel scafolds, compared to those 
of the 0.5 mg/mL HAPna containing systems. Studies 
have shown that cells are able respond to the stifness 
of their substrate and hence the mechanical properties 
of the hydrogel scafold can inluence cell function and 
diferentiation (Discher et al., 2005, Wang et al., 2012). 
Thus, the stifer hydrogel matrix provided by the addition 
of 0.5 mg/mL HAPna could account for the improved 
osteoconductivity observed in these constructs compared 
to hMSC hydrogels containing 1.0 mg/mL HAPna. 
The mechanical properties of HAPna loaded hydrogels 
displayed here still fall short of those of native bone, which 
have been reported to display elastic moduli of 14-20 GPa 
(cortical bone) (Reilly et al., 1974; Rho et al., 1993; Rho 
et al., 1997). However, it is hypothesised that the initial 
mechanical properties of hydrogel scafolds would not 
need to match that of native bone, particularly when used 
Fig. 10. Injection into bone simulation: (A) still images captured from video which demonstrates liquid L-pNIPAM-
co-DMAc hydrogel with 0.5 mg/mL HAPna, cooled to 39 °C in a water bath and injected (26 gauge) into a glass vial, 
followed by rapid solidiication inside a temperature controlled glove box set to 37 °C. (B) Schematic illustrating 
liquid L-pNIPAM-co-DMAc hydrogel cooled to 39 °C (above the gelation temperature) where the hydrogel exists 
as a low viscosity colloidal suspension where HAPna and hMSC can be incorporated. Following injection into the 
bone tissue and further cooling to 37 °C the polymer chains uncoil and entangle forming a 3-dimensional hydrogel 
network, encapsulating both the HAPna and the hMSC. (C) Injection of L-pNIPAM-co-DMAc hydrogel, with a blue 
dye incorporated for visualisation, into bovine tail vertebra.
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to deliver hMSC for clinical cases such as osteoporosis 
and lining of prosthetic implants; in such cases, the native 
bone surrounding the implantation site would provide the 
initial mechanical support whilst the hydrogel becomes 
mineralised by the regenerative capacity of the cells, thus 
resulting in a biologically functional and integrated tissue/
biomaterial. Furthermore, the use of a non-degradable 
injectable scafold would be advantageous over current 
therapeutic alternatives in such clinical cases, enabling 
the facile application to micro issures within the bone and 
avoiding loss of mechanical properties seen during scafold 
degradation in biodegradable scafolds (Kim et al., 2007, 
Lutolf and Hubbell, 2005).
Structural and compositional requirements for bone 
regeneration
Bone ECM has a unique hierarchical anisotropic structure 
from nano- to macro-scale (Rho et al., 1998). The macro 
structure can be divided into cortical or cancellous bone, 
which microstructurally consists of harversian systems 
and trabecular respectively (Weiner and Traub, 1992). 
The nanostructure is composed of fibrillar collagen, 
embedded mineral and non-collagenous proteins including 
osteopontin, osteocalcin, osteonectin and bone sialoprotein, 
which contribute to the orientation and size of the 
HAP crystals (Nakano et al., 2002; Rho et al., 1998); 
consequently, replicating this complex hierarchically 
organised structure in order to efectively provide the 
diverse mechanical, biological and chemical functions of 
bone ECM is a signiicant challenge for tissue engineering 
and regenerative medicine based strategies. The size 
and distribution of pores within biomaterial scafolds is 
crucial in dictating cellular behaviour, iniltration and 
distribution as well as the difusion of nutrients and waste 
products (Annabi et al., 2010). The incorporation of cells 
in the liquid state prior to gelation also ensures that the 
interconnecting porous network is able to assemble around 
the cells. The increase in structural density and reduction 
in pore size observed in hMSC hydrogels with 0.5 mg/mL 
HAPna is likely to be due to both a signiicant decrease 
in the hydration degree, where hMSC were incorporated 
into hydrogel scafolds, in comparison to acellular controls 
and hMSC depositing matrix within pores, both of which 
contribute to the increase in mechanical properties 
observed where hMSCs were added into hydrogel scafolds 
in comparison to acellular controls.
 The composition of the matrix was assessed 
histologically and found to consist of collagen, identiied 
by Masson’s trichrome and calcium conirmed by alizarin 
red staining. Mineralisation was further supported by the 
identiication of a calcium and phosphate peak, observed 
using EDX spectra. Histologically, cells were also shown 
to be producing proteoglycans as observed by Alcian Blue 
staining; however, increased matrix staining intensity was 
also observed in acellular controls, thus the increase in 
staining intensity could be due to an increase in background 
staining. Unfortunately, biochemical quantiication of 
matrix composition was not possible as the hydrogel 
system was non-digestible to enable release of factors 
for analysis, hence semi quantiication was performed 
on histological analysis. Furthermore, examination by 
immunohistochemistry identified collagen type I and 
increased expression and deposition of osteocalcin and 
osteopontin throughout the 6 week culture period. The 
increase in matrix deposition was also supported by a 
signiicant increase in the dry mass of hMSC hydrogel 
scafolds after 6 weeks in culture containing 0.5 mg/mL 
HAPna.
 A second contributing factor to the signiicant decrease 
in pore size may also be due to the hydration degree of the 
hydrogel scafolds. The hydration degree of biomaterial 
scafolds is a crucial indicator of cellular iniltration and 
important in the difusion of nutrients and waste products 
(Annabi et al., 2010). The signiicant reduction in hydration 
degree is likely due to cell contraction forces when the 
intracellular tension is exerted to the ECM through focal 
adhesions, resulting in physical links between the ECM and 
the actin cytoskeleton (Li and Wang, 2010). These forces 
play an essential role-enabling cell migration (Pourati et 
al., 1998), mechanical sensing and controlling cell shape 
and tensional homeostasis (Beningo and Wang, 2002; 
Brown et al., 1998). This phenomenon has been replicated 
elsewhere where cells were shown to contract and reduce 
the size of collagen matrix in vitro (Ehrlich and Rajaratnam, 
1990). A signiicant decrease in the hydration degree of 
hMSC hydrogel constructs with 1.0 mg/mL HAPna was 
observed from 48 h to 2 weeks, despite a decrease in 
metabolic cell activity, indicating cytotoxicity, observed 
in these constructs up to 7 d. No signiicant diference in 
the hydration degree of hMSC hydrogel constructs with 
1.0 mg/mL HAPna was observed from 2 to 6 weeks in 
culture, which could suggest that that after 2 weeks cells 
are mainly dead. It is possible that viable cells, which 
were present in the initial days of culture, were able to 
constrict the size of the construct with resultant loss in 
water content; this relects the substantial reduction in 
hydration degree which is observed from 48 h to 1 week 
in culture. Following the initial loss in water, it is likely 
that re-swelling of the hydrogel to restore the hydration 
degree, does not take place regardless of whether the cells 
are alive or dead, since the hydrogel is being cultured at 
the gelation temperature (37 °C).
 Compositionally, we have shown that the L-pNIPAM-
co-DMAc hydrogel supplemented optimally with 0.5 mg/
mL HAPna induces matrix synthesis, consisting of collagen 
and non-collagenous proteins such as osteocalcin and 
osteopontin, together with increased deposition of calcium 
mimicking native bone matrix. Despite this, structural 
regeneration of bone ECM in vitro which replicates 
the native anisotropic structure represents a signiicant 
challenge (Ishimoto et al., 2013, Nakano et al., 2002). 
Patterning of ECM deposition can be inluenced by cell 
orientation (Wang et al., 2003), anisotropic mechanical 
environment (Matsugaki et al., 2013) and in response 
to external stimuli (Matsugaki et al., 2015), thus it is 
hypothesised that regeneration of bone matrix in vitro 
which consists of the correct nanostructural components 
will only truly replicate the complex hierarchical structure 
of bone in vivo where cells are subjected to the native 
biological, chemical and physical microenvironmental cues 
which induces speciied cellular and tissue arrangement.
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Induction of osteogenic diferentiation
The development of a biomaterial scafold that promotes 
repair and regeneration of bone ECM is reliant on the 
bioactivity of the biomaterial and its ability to promote 
and facilitate osteogenic activity with consequential 
mineralisation. Bone tissue forms by eventual diferentiation 
of MSCs to osteoblasts that synthesise and deposit collagen 
type I, the main ECM component of bone matrix (Shapiro, 
2008). In the current study the ability of 0.5 mg/mL 
HAPna loaded L-pNIPAM-co-DMAc hydrogels to induce 
osteogenic diferentiation of bone marrow derived hMSCs, 
without the use of osteogenic growth factors was assessed 
immunohistochemically. The ubiquitous expression of 
Collagen type X in hMSCS suggests evidence of pre-
diferentiation; however, bone marrow derived MSCs 
have been shown to express collagen type X (Jacenko 
et al., 1996; Mwale et al., 2006); thus, collagen type X 
cannot be considered as a deinitive marker of hypertrophic 
chondrocytes. Runx2 is regarded as the fundamental 
transcription factor required for osteogenic diferentiation 
of MSCs to fully differentiated osteoblasts, resulting 
in the up-regulation of osteogenic proteins including 
collagen type I, osteopontin and osteocalcin (Ducy et al., 
1997). The increased Runx2 expression, followed by a 
signiicant down regulation after 2 weeks in culture, is 
typical of Runx2 expression seen during diferentiation 
of pre-osteoblasts to mature osteoblasts (Komori, 2010; 
Maruyama et al., 2007). The early bone matrix marker, 
collagen type I, as well as osteopontin and osteocalcin, 
two late phase markers of mature osteogenesis, which 
have cell and calcium binding domains (Lian and Stein, 
1992) and have been shown to be upregulated following 
the onset of mineralisation (Sodek and Cheifetz, 2000), 
were highly expressed by hMSCs following 6 weeks in 
culture, after incorporation into 0.5 mg/mL HAPna loaded 
hydrogel nanocomposite scafold. Collagen type I was 
found to be highly expressed by hMSC prior to hydrogel 
incorporation which could suggest pre-diferentiation of 
the cells since the hMSCs are derived from bone marrow; 
however, the percentage of hMSCs expressing late phase 
osteogenic protein markers (osteopontin and osteocalcin) 
were only signiicantly increased following incorporation 
in 0.5 mg/mL HAPna containing L-pNIPAM-co-DMAc 
hydrogel constructs; thus demonstrating the bioactive 
properties of this hydrogel system with diferentiation 
of MSCs into mature osteoblasts capable of depositing 
a bone like matrix rich in calcium, demonstrated by 
Alizarin red staining and the formation of possible osteoid 
nodules, determined by the identiication of calcium and 
phosphate peaks, following 6 weeks in culture, by EDX 
spectra. Whereas expression of chondrogenic markers, 
aggrecan and collagen type II, remained unchanged or were 
signiicantly decreased – thus conirming the osteogenic 
phenotype of MSCs incorporated into hydrogel constructs 
containing 0.5 mg/mL HAPna. The viability and osteogenic 
diferentiation of late passage hMSCs within L-pNIPAM-
co-DMAc hydrogel constructs loaded with 0.5 mg/
mL HAPna, is encouraging, since stem cells extracted 
from elderly patients, whom degenerative bone diseases 
typically afflict, have been shown to have a reduced 
capacity for proliferation and diferentiation (Stolzing 
et al., 2008). However, the osteogenic diferentiation of 
hMSC demonstrated here was performed with one donor 
at passage nine; therefore, caution in interpreting these 
results should be considered.
 A variety of bioactive injectable hydrogel scafolds 
have been reported; however, many systems preclude the 
incorporation of cells in the liquid state as they require 
co-injection with cross linking agents (Halacheva et al., 
2014; Lally et al., 2007; Saunders et al., 2007; Shin et al., 
2003). Other systems are too viscous for injection through 
ine-bore needles, which may limit the potential number 
of bone repair clinical applications and result in further 
damage to the target site (Michalek et al., 2010; Nassr et 
al., 2009). Other hydrogels, alternative to pNIPAM/HAP 
hydrogels for MSC delivery, have been reported; however, 
the viability of cells incorporated prior to gelation has not 
always been assessed (Couto et al., 2009) or the use of 
growth factors has been necessary to induce osteogenesis 
(Kim et al., 2007; Martínez-Sanz et al., 2011; Kim et al., 
2007; Kim et al., 2011; Liao et al., 2011; Martínez-Sanz 
et al., 2011; Na et al., 2007). The L-pNIPAM-co-DMAc 
hydrogel system described here is processed in a novel 
manner, whereby synthesising pNIPAM at 80 °C (i.e. 
above the gelation temperature) on the surface of dispersed 
Laponite platelets, we are able to produce a colloidal 
nanosuspension that remains a low viscosity liquid if held 
above the gelation temperature (37.1 ± 0.16 °C). Upon 
cooling, the pNIPAM chains convert from the globule 
to the coil conformation, become entangled and form a 
gel, supported by physical crosslinks with the Laponite 
platelets, that does not melt upon reheating. This is indeed 
unlike other pNIPAM based hydrogels, and generates a 
hydrogel with lower viscosity than previously reported 
systems, which has the potential to ill small cracks, issures 
and voids within the bone. In addition, growth factor free 
approaches to injectable composite hydrogels for use in 
bone augmentation have been limited; recently, Xavier et 
al. (2015) reported nanocomposite hydrogels capable of 
promoting osteogenesis in the absence of osteoconductive 
factors; however, the scaffold fabrication technique 
involved the use of photo crosslinking which raises safety 
concerns regarding UV exposure not only to implanted 
cells but also to surrounding tissues during delivery and 
precludes the use of minimally invasive techniques for 
deeper tissues (Xavier et al., 2015).
 The current study utilised a bioceramic copolymer 
nanocomposite hydrogel loaded with HAPna, which is 
cytocompatible in the liquid state and requires no clean 
up or further puriication, has a low viscosity suicient to 
facilitate injection through a ine needle (26 gauge) prior 
to gelation at body temperature (37 °C) and has excellent 
osteoconductive properties providing a microenvironment 
that influences the differentiation fate of MSCs with 
induced expression of both early and late phase osteogenic 
proteins and formation of a mineralised matrix without 
the need for additional osteogenic inducing factors. The 
osteogenic inductive properties of this hydrogel system 
preclude the need for additional bioactive factors which 
will reduce regulatory requirements and clinical costs thus 
making such a system more favourable for therapeutic 
application. Future investigations should be conducted to 
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assess the osteogenic inductive properties of this hydrogel 
with MSCs extracted from a large cohort of human patients 
to determine patient variability and age of patients which 
can be utilised.
Conclusion
The current study used a HAPna loaded L-pNIPAM-co-
DMAc nanocomposite hydrogel to induce osteogenic 
diferentiation of hMSCs and thus regenerate a mineralised 
matrix. Although there are many studies using HAP 
biomaterials for bone regeneration, this synthetic hydrogel 
addresses several clinical requirements in one biomaterial. 
It is cytocompatible in the liquid state and thus enables 
safe and homogenous encapsulation of cells and HAPna, 
the fabrication technique utilised does not require 
additional chemicals to be added for gelation or clean up 
and the hydrogel undergoes gelation at body temperature. 
Furthermore, following cellular incorporation, the 
hydrogel containing HAPna, was capable of inducing 
osteogenic diferentiation of MSCs without the addition 
of growth factors. This has key implications because 
such a therapeutic strategy could utilise the patient’s 
own MSCs and be injected directly into the target site 
without the need for external biological manipulation, 
thus reducing treatment costs, simplifying the treatment 
strategy regulatory requirements and potentially providing 
safe and eicacious repair and regeneration of lost bone.
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Discussion with Reviewers
Reviewer I: As this hydrogel is non-degradable and 
does not really prone host cells migration and tissue 
iniltration, we can question if, following implantation, 
the angiogenesis will be fast enough to create a functional 
bone tissue.
Authors: Within bone tissue, cells reside in close 
proximity to blood vessels that crucially supply tissues 
with oxygen and nutrients and facilitate the removal 
of carbon dioxide as well as other waste products; 
thus the regeneration of a functional bone matrix is 
reliant on the eicient vascularisation of the injected 
L-pNIPAM-co-DMAc hydrogel reported in this study. 
Chiu et al., 2011 demonstrated that scafold pore size 
influences neovascularisation with pores (25-50 µm) 
limiting neovascularisation to the external surface of 
the hydrogel (Chiu et al., 2011). The synthetic route 
employed in this study uniquely results in a 3-dimensional 
polymeric network, which is ixed in terms of its state 
but is simultaneously able to facilitate polymer chain 
displacement so that cells are able to migrate through 
the hydrogel, independent of pore size; thus despite the 
hydrogel being non-degradable it does facilitate cellular 
migration. Furthermore, we have demonstrated that 
HDMEC cells, which are capable of neovascularisation, 
were able to migrate through the entire length of a 10 mm 
thick pre-set hydrogel construct following 2 weeks in 
culture (Fig. DWR1). It is envisaged that this hydrogel will 
be most suited as a support scafold to deliver regenerative 
cells for bone repair applications such as small non-union 
fractures, artificial joint fixation and osteoporosis as 
opposed to large defects; thus it is likely that the distance, 
and resultant time taken, for cell migration into the 
hydrogel scafold in vivo to induce vascularisation will 
be suicient to facilitate the survival of transplanted cells 
and functional integration of the scafold with surrounding 
bone tissue.
Reviewer I: The new Fig. DWR1 does not really 
bring any clear supplementary information. The green 
autoluorescence background of the gel is really high 
and we observe only scarce clusters of cell agglomerated 
altogether. In fact, those cells do not exhibit ‘migrating 
phenotype’ as illustrated by the schematics on the left side 
of this igure. From my point of view, this igure does not 
persuade ECM readers to the suitability of this hydrogel 
to be vascularised following implantation.
Authors: Fig. DWR1 demonstrates a cross section of 
hydrogel following 2 weeks after loading HDMEC cells on 
top of pre-set 10 mm thick hydrogel constructs. Due to the 
autoluorescence of the hydrogel, which is unfortunately 
unavoidable, the migrating phenotype of cells cannot be 
accurately visualised. Despite this, cellular bodies can 
be visualised at the surface of the hydrogel, and within 
the deeper layers; therefore, we feel HDMEC cells must 
have migrated through the material. We agree that this 
alone does not provide suicient evidence to suggest 
that vascularisation of the hydrogel in vivo would be 
eicient enough to enable integration of the scafold and 
subsequent repair of surrounding bone tissue; however, this 
does demonstrate that HDMEC cells, which are capable 
of neovascularisation, are able to migrate through the 
hydrogel; future studies are required to further investigate 
the vascularisation of the hydrogel, which is essential to 
facilitate regeneration of a functional bone matrix. We have 
ensured this is now conveyed in our response.
Reviewer III: The authors present an interesting composite 
biomaterial with an atypical gelation mechanism, which is 
shown to support MSC diferentiation to bone cells in vitro. 
However, the material is non-degradable. Do the authors 
think that this could be a limitation?
Authors: We hypothesise that the non-biodegradable 
nature of the L-pNIPAM-co-DMAc hydrogel with HAPna, 
developed here, would not be a limitation since it reduces 
issues associated with scafold degradation such as the 
toxicity of degradation products as well as the challenge 
of matching scafold degradation with matrix regeneration, 
which inevitably will be patient dependent. It is envisaged 
that the non-biodegradable hydrogel will provide long term 
scafold support whilst the newly synthesised bone tissue 
will undergo natural tissue remodelling to regenerate a fully 
integrated and functional bone/scafold matrix; however, 
future in-vivo investigations are essential to determine the 
long term fate of this hydrogel as a non-biodegradable cell 
carrier scafold.
Reviewer III: The authors highlighted that the use of a non-
biodegradable and injectable system is more advantageous 
than the current therapeutic alternatives because it enables 
the easy application to micro issures within the bone, and 
avoids loss of mechanical performance seen during scafold 
degradation in other biodegradable systems. Taking into 
account the classical approach in which scafold degrades 
allowing cells to colonize and to form new tissue, I would 
suggest considering this injectable system as a carrier, 
to support cell diferentiation, rather than a scafold. It is 
still unclear how this non-biodegradable construct would 
facilitate bone tissue regeneration as it remains at the 
implant site. The authors should further explain the inal 
application of this material.
Authors: The cytocompatibility and low viscosity of the 
L-pNIPAM-co-DMAc hydrogel, developed here, enables 
the delivery of regenerative cells by minimally invasive 
injection followed by in-situ gelation to assist in the natural 
repair and regeneration of bone matrix. Reviewer 3 is 
correct that an important application of this hydrogel is 
that it can be used as an injectable cell carrier to promote 
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Fig. DWR1. Human Dermal Microvascular Endothelial Cells (HDMEC) (2 × 106 cells/mL), labelled with a luorescent 
CFSe stain for tracking, layered on top of 10 mm thick pre-set L-pNIPAM-co-DMAc hydrogel constructs with 0.5 mg/
mL HAPna and cultured for 2 weeks. Representative images of HDMEC cells from the top, middle and bottom of 
hydrogel constructs; demonstrating cell migration through the entire length of the hydrogel.
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osteogenic cellular diferentiation of transplanted stem 
cells and thus regenerate bone matrix. The low viscosity 
nature of this system also enables the liquid hydrogel to 
ill micro and macro fractures prior to solidiication at 
37 °C. Within small bone defects, we hypothesise that 
the hydrogel will provide a scafold between adjacent 
surfaces of native bone tissue, which will provide initial 
mechanical support, facilitate the migration of native cells 
to aid tissue integration as well as promote osteogenic 
differentiation of transplanted cells to regenerate a 
functionally integrated bone matrix. We envisage that 
this non-biodegradable hydrogel scafold will provide 
long term support, whilst the regenerated matrix within 
and surrounding the hydrogel undergoes natural tissue 
remodelling. The non-biodegradable properties of this 
hydrogel avoid issues associated with scafold degradation 
such as toxicity of degradation products as well as the 
challenge of matching scafold degradation with matrix 
regeneration which inevitably will be patient dependant. 
For the repair of small bone defects, as well as clinical 
cases of osteoporosis, the L-pNIPAM-co-DMAc hydrogel 
could provide the beneicial properties of both a carrier and 
a scafold; however, for larger bone defects the hydrogel 
is likely to be mechanically insuicient and thus may be 
applied as a cell delivery scafold, in combination with an 
additional support scafold, to promote the regeneration 
and integration of bone tissue. The promising results 
obtained here in vitro suggest that this L-pNIPAM-co-
DMAc hydrogel could utilise the patient’s own MSCs 
to regenerate bone tissue, without the need for external 
biological manipulation; however, future in vivo studies 
are essential to fully elucidate the long term fate of this 
hydrogel within bone tissue.
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